Kamble Milind Dharmraj, Gaikwad Mahesh, Marathe Rajendra, Shirsat Mahendra, Tapadiya Ganesh
Department of Pharmaceutics & Biopharmaceutics, Shreeyash Institute of Pharmaceutical Education & Research, Aurangabad, Gut No. 258, Behind SRPF Camp, Satara Parisar Aurangabad, India.
Department of Pharmaceutics, Ph.D. Scholar, Government College of Pharmacy, Aurangabad, India.
Pharm Nanotechnol. 2025;13(2):328-340. doi: 10.2174/0122117385279456240329041704.
Gold nanoparticles (GNP) have been used extensively in cancer biologics and as drug carrier systems for improved pharmacokinetics and effective therapeutic action. GNPs also ensure reliable diagnosis with sensitive imaging.
This study aimed to synthesize tizanidine hydrochloride (TZN)-biodegradable gold (Au) nanoparticles by the reduction of chloroauric acid (HAuCl4) with trisodium citrate using a microwave synthesizer and quality by design approach.
The formulation method used was optimized using a 3 (two-factor, three-level design) factorial experiment. Temperature (X1) and concentration of gold salt (X2) were the two independent factors, and particle size (Y1), Percent drug entrapment efficiency (Y2), and polydispersity index (Y3) were the responses recorded for the study.
The results of the study revealed that the optimized nanoparticles (TGN8) had a particle size (Y1) of 195 ± 1.2 nm, a polydispersity index of 0.2, and entrapment efficiency of 99.0 ± 2.9% at an optimized concentration of 14 mM gold salt (X1) and 100°C temperature (X2). Atomic Force Microscopy showed the spherical shape particles. drug release was found to be 62.1 ± 0.5% release of TZN in simulated gastric buffer (pH 1.2) and 45.5 ± 2.8% in physiological buffer (pH 7.4).
Overall, the study identified the optimal formulation conditions for TZN GNPs by considering the effects of independent variables on desired responses.
金纳米颗粒(GNP)已广泛应用于癌症生物制剂领域,并作为药物载体系统以改善药代动力学和实现有效的治疗作用。金纳米颗粒还可通过灵敏成像确保可靠的诊断。
本研究旨在使用微波合成仪,通过柠檬酸钠还原氯金酸(HAuCl4),采用质量源于设计的方法合成盐酸替扎尼定(TZN)-可生物降解金(Au)纳米颗粒。
使用3(双因素、三水平设计)析因实验对所采用的制剂方法进行优化。温度(X1)和金盐浓度(X2)为两个独立因素,粒径(Y1)、药物包封率(Y2)和多分散指数(Y3)为该研究记录的响应指标。
研究结果显示,优化后的纳米颗粒(TGN8)在金盐优化浓度为14 mM(X1)、温度为100°C(X2)时,粒径(Y1)为195±1.2 nm、多分散指数为0.2、包封率为99.0±2.9%。原子力显微镜显示颗粒呈球形。在模拟胃液缓冲液(pH 1.2)中盐酸替扎尼定的药物释放率为62.1±0.5%,在生理缓冲液(pH 7.4)中为45.5±2.8%。
总体而言,本研究通过考虑自变量对预期响应的影响,确定了盐酸替扎尼定金纳米颗粒的最佳制剂条件。